Home > News > Innovation From Down Under
October 5th, 2005
Innovation From Down Under
Jack Uldrich: First, pSivida announced that it is acquiring Boston-based Control Delivery Systems, a U.S. drug-delivery company, for $104 million. The deal, if shareholders of both companies approve, will go a long way toward helping pSivida capitalize on its plans to commercialize its BioSilicon drug delivery platform.
Starpharma, meanwhile, announced that it has received $20 million grant from the U.S.-based National Institute of Allergy and Infectious Diseases to help accelerate the progress of VivaGel to market.
Harris & Harris Group Notes ABSMaterials' Series B Financing November 22nd, 2013
Harris & Harris Group Letter to Shareholders on Website November 18th, 2013
Harris & Harris Group Reports Financial Statements as of September 30, 2013 November 12th, 2013
Harris & Harris Group Notes CordenPharma's Acquisition of Ancora's Carbohydrate Synthesis Platform and Corporate Name November 7th, 2013